Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Biologie Aujourd'Hui|April 12, 2019
[Immunotherapy and bladder cancer]Louis Lenfant, Morgan Rouprêt
International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2021
Predictive factors of postoperative complications and hospital readmission after implementation of the single-port robotic platform: A single-center and single-surgeon experienceLouis Lenfant, Alireza Aminsharifi, Soodong Kim, et al.
European Urology|March 20, 2023
First-line Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer: Chimera or "Ne Plus Ultra"?Louis Lenfant, Ugo Pinar, Morgan Rouprêt, et al.
Current Opinion in Urology|March 7, 2020
Current status and future directions of the use of novel immunotherapeutic agents in bladder cancerLouis Lenfant, Alireza Aminsharifi, Thomas Seisen, et al.
European Urology Focus|July 8, 2020
Single-institution Cost Comparison: Single-port Versus Multiport Robotic ProstatectomyLouis Lenfant, Guilherme Sawczyn, Soodong Kim, et al.
Minerva Urology and Nephrology|December 1, 2020
Predictive factors for opioid-free management after robotic radical prostatectomy: the value of the SP® robotic platformGuilherme Sawczyn, Louis Lenfant, Alireza Aminsharifi, et al.
World Journal of Urology|July 1, 2020
Floating docking technique: a simple modification to improve the working space of the instruments during single-port robotic surgeryLouis Lenfant, Soodong Kim, Alireza Aminsharifi, et al.
European Urology Oncology|August 16, 2023
Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer DiagnosisLouis Lenfant, Thomas Seisen, Morgan Rouprêt, et al.
European Urology|February 26, 2022
Transperineal Prostate Biopsy Is the New Black: What Are the Next Targets?Louis Lenfant, Eric Barret, Morgan Rouprêt, et al.
Pageof 5